Winslow Evans & Crocker’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CM
Winslow Evans & Crocker's IBB Position: Q4 2020 in Review
Winslow Evans & Crocker increased its iShares Biotechnology ETF (IBB) stake by 32% in Q4 2020, buying an estimated $5.72K and bringing the position to 165 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #739.
Winslow Evans & Crocker first reported a position in IBB in Q1 2014 and has held it in 21 quarters since. The position peaked at $129K in Q4 2015. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.
- Winslow Evans & Crocker held 165 shares of iShares Biotechnology ETF worth $25K as of Q4 2020.
- Winslow Evans & Crocker bought 40 iShares Biotechnology ETF shares in Q4 2020, an estimated $5.72K.
- iShares Biotechnology ETF made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #739 holding.
- Winslow Evans & Crocker first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 21 quarters since.
- Winslow Evans & Crocker's iShares Biotechnology ETF position peaked at $129K in Q4 2015.
- 856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.
Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.